Peter W Dunten

Title: The Innovations of Peter W. Dunten

Introduction

Peter W. Dunten is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of xanthine derivatives. With a total of 2 patents, his work has implications for modulating gluconeogenesis, which is crucial for metabolic processes.

Latest Patents

Dunten's latest patents include "Sulfonamide Substituted Xanthine Derivatives" and "Amide Substituted Xanthine Derivatives." The first patent describes a sulfonamide substituted xanthine derivative of formula I, which can be a pharmaceutically acceptable salt. The compounds show activity as modulators of gluconeogenesis, with specific structural characteristics defined in the patent. The second patent focuses on a 1,3,8 substituted xanthine derivative, also demonstrating similar activity in modulating gluconeogenesis.

Career Highlights

Peter W. Dunten is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this organization has allowed him to explore innovative solutions in drug development and contribute to advancements in medical science.

Collaborations

Dunten has collaborated with notable coworkers such as Weiya Yun and Nicholas J. S. Huby. These partnerships have likely enhanced the research and development efforts in their respective projects.

Conclusion

Peter W. Dunten's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the understanding and treatment of metabolic processes.